Navigation Links
Another Cause of Thyroid Cancer Discovered

A new discovery reveals a new cause of thyroid cancer. Researchers say in 70 percent of papillary thyroid tumors, one of three genetic changes // happen. The genes affected include BRAF, RET or RAS. When patients have not been exposed to radiation, the changes generally happen with the BRAF gene. However, in patients who are exposed to radiation the gene changes occur in the RET gene. In both cases, the gene changes or mutations transform normal cells into malignant cells.

A recent study has uncovered a novel gene mutation , researchers say part of the AKAP9 gene and the BRAF gene are involved. The fusion of these genes results in BRAF signaling normal cells to transform into malignant cells. This is a new discovery of cause for patients with thyroid tumors.

Researchers conclude saying the discovery of the chromosomal rearrangement is remarkable and they add that their findings represent a major breakthrough in the knowledge of genetic events involved in the cause of papillary thyroid tumors.
'"/>




Page: 1

Related medicine news :

1. Another ray of hope for Arthritis Sufferers
2. Another injectable contraceptive Pill approved by FDA
3. The Possibility Of Fighting HIV with Another Virus Questioned
4. New Research Has Found Another Use For Botox
5. Yet Another Harmful Consequence Of Smoking
6. Another Treatment Option for Benign Tumors
7. Yet Another Treatment Option For Cancer
8. Another Alternative For Diabetics On Insulin
9. Another Use For Epilepsy Drugs
10. Yet Another Use For Cell Phone Cameras
11. Yet Another Use For Cocoa Flavonols
Post Your Comments:
(Date:5/22/2008)...Invasive P3(TM) (Pioneer Peek-on-Peek) ...ERGEN, Netherlands, May 22 /PRNewswire/ -- Pioneer...nnounced the BacJac(TM),Interspinous Decompression...ring the International SpineWeek meeting in Geneva...relieve pain in patients with,Neurogenic Intermitt...
(Date:5/22/2008)...Newswire/ -- Whether your summer travel,plans incl... an older adult,there are things you should do bef...ng to Timothy Schwab, M.D., chief medical officer ...ply whether you,re planning to go,out of the count... travel plans with your doctor. If you are (or rec...
(Date:5/22/2008)...May 22, 2008) For patients undergoing kidney tran...g sirolimus may lead to an increased risk of diabe...erican Society of Nephrology (JASN). , "We demon... diabetes after transplantation in a large group o...s," comments Dr. John S. Gill of University of Bri...
(Date:5/22/2008)...-USNewswire/ -- Generation Rescue, a,non-profit or... Autism,ADHD and chronic illness, today announced...ajor steps:, 1. Jenny McCarthy, Deirdre Imus and ... Ms. McCarthy is a best-selling author, actress, a...m autism. Her latest book, Louder than Words,prof...
Breaking Medicine News(10 mins):Health News:Pioneer(R) Surgical Technology Introduces the BacJac(TM) Interspinous Decompression System to the European Spine Market 2Health News:SCAN Health Plan Offers Seniors Ten Tips for Safe and Healthy Travel 2Health News:Anti-rejection drug may increase risk of diabetes after kidney transplant 2Health News:Generation Rescue to Target Treatment-Based Research for Autism and ADHD - Jenny McCarthy, Deirdre Imus, and Katie Wright Join Board 2Health News:Generation Rescue to Target Treatment-Based Research for Autism and ADHD - Jenny McCarthy, Deirdre Imus, and Katie Wright Join Board 3
...ernment is facing accusation from the Victorian Op...ces in the state. // Reports are rife that almost... a month of being discharged from the hospital, ne...ey confirms that the auditor-general had fore-warn...
...ublished in the March 15, 2006 issue of CANCER, a ...ty, says that the risk of a //new cancer occurring...cer increases to a fair degree in women diagnosed .... The study also says that the risk of developing ...
...roposed by the Jharkhand government to donate near...t the potential of Ayurveda.// The yoga guru has a...ure and marketing of Ayurvedic medicine preparatio... medicinal plants. The government is likely to si...
...ia has been long considered a wonderland for smoke...bbies or restaurants without any inhibition. // Sa...t is seriously thinking about imposing a smoking b...In Malaysia and Thailand, smoking bans already exi...
Other Medicine News:Health News:Smoking Ban To Be Soon Implemented In South East Asian Bars 2
(Date:5/21/2008)...1 /- Pressure,BioSciences, ... scientists,from the New York University (NYU) Sch... the Harvard School of Public Health made presenta... patented pressure cycling,technology (PCT) at thr....,There were three oral presentations and four pos...
(Date:5/21/2008)...an Urological Association Annual Meeting -, SEATT.../ -- Researchers,from Dendreon Corporation (Nasdaq...rating the potential of D-3263, Dendreon,s orally ...(a transmembrane cation channel protein also,known... (BPH)., The abstract (#2041), "Preclinical Valid...
(Date:5/20/2008)...ay 21 /- Today at the,World...e entitled "New,Perspectives in Atrial Fibrillatio...linical Cardiology, St George,s University of Lond...ced ATHENA clinical trial,results, as the way forw...n, the most common form of cardiac arrhythmia., T...
(Date:5/20/2008)...ed today at Digestive Disease Week -, CAMBRIDGE, ...--,Ironwood Pharmaceuticals, Inc. (formerly Microb...X ) today announced the presentation of data,from ...olled study,assessing the safety and efficacy of l...CC). Analysis of these data indicate that linaclot...
Breaking Medicine Technology:Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 2Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 3Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 4Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia 2Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia 3Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia 4ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 2ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 3ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 4ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 5ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 6Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 2Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 3Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 4Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 5Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 6Nucletron Announces Oncentra 28R 29 Brachy Treatment Planning Solution for Multimodality Environment 4906 1Nucletron Announces Oncentra 28R 29 Brachy Treatment Planning Solution for Multimodality Environment 4906 2Terumo Heart Summarizes Results of DuraHeart 28TM 29 LVAS Implants 1913 1Terumo Heart Summarizes Results of DuraHeart 28TM 29 LVAS Implants 1913 2Will you be misdiagnosed 3F how diagnostic errors happen 17851 1Will you be misdiagnosed 3F how diagnostic errors happen 17851 2Will you be misdiagnosed 3F how diagnostic errors happen 17851 3American Chemical Societys Weekly PressPac April 23 2008 3076 1American Chemical Societys Weekly PressPac April 23 2008 3076 2American Chemical Societys Weekly PressPac April 23 2008 3076 3American Chemical Societys Weekly PressPac April 23 2008 3076 4American Chemical Societys Weekly PressPac April 23 2008 3076 5American Chemical Societys Weekly PressPac April 23 2008 3076 6American Chemical Societys Weekly PressPac April 23 2008 3076 7American Chemical Societys Weekly PressPac April 23 2008 3076 8
...r 7, 2007 - Gemin X,announced today that a report ...od demonstrated that its lead compound, GX15-070,(...inst,patient-derived multiple myeloma tumor cells ...ts when used as a combination therapy.,GX15-070 is... all,relevant members of the Bcl-2 protein family,...
...erican College of,Cardiology,s Scientific Session ...irstCall/ -- CV,Therapeutics, Inc. announced today...N TIMI-36 study of ranolazine shows there was no,a...n ranolazine.,The study did not meet the primary e...,s special protocol assessment,agreement with the ...
Other Medicine Technology:Gemin X Announces Publication of Preclinical Data of GX15-070 in,Multiple Myeloma in Blood 2CV Therapeutics Announces Topline MERLIN TIMI-36 Results 2CV Therapeutics Announces Topline MERLIN TIMI-36 Results 3
ORTHOSET Radiopaque Bone Cement consists of a two component system: a sterile,ampule containing bone cement liquid within a blister pack, and a sterile polyethylene bag,containing bone cement pow
Low viscosity bone cement without antibiotics for syringe use with an average setting time of approx. 7-9 Min., 40g of powder and 14.6g of liquid.
...eoscope represents new thinking to address common ... eliminating a 5.85 mm diameter outer arthroscope ...diameter Videoscope has superior access and mobili...and especially in the elbow and ankle. In conjunct...
... llifestly of hypertensive and hopotensive patient...sociated with blood pressure monitoring conducted ...ep instrument, it enables physicians to conduct ro...f ther patient's homes. With its built-in proprie...
Medicine Products: